A whale with a lot of money to spend has taken a noticeably bullish stance on Aurinia Pharmaceuticals.
Looking at options history for Aurinia Pharmaceuticals AUPH we detected 10 strange trades.
If we consider the specifics of each trade, it is accurate to state that 70% of the investors opened trades with bullish expectations and 30% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $106,666 and 7, calls, for a total amount of $216,391.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $5.0 to $13.0 for Aurinia Pharmaceuticals over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Aurinia Pharmaceuticals's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Aurinia Pharmaceuticals's whale trades within a strike price range from $5.0 to $13.0 in the last 30 days.
Aurinia Pharmaceuticals Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| AUPH | CALL | SWEEP | BEARISH | 04/14/22 | $13.00 | $46.7K | 267 | 514 |
| AUPH | PUT | SWEEP | BULLISH | 03/18/22 | $11.00 | $35.9K | 1.2K | 490 |
| AUPH | PUT | SWEEP | BULLISH | 04/14/22 | $10.00 | $35.7K | 1.1K | 868 |
| AUPH | PUT | TRADE | BULLISH | 03/18/22 | $10.00 | $35.0K | 1.8K | 1.5K |
| AUPH | CALL | TRADE | BULLISH | 07/15/22 | $12.00 | $30.7K | 818 | 279 |
Where Is Aurinia Pharmaceuticals Standing Right Now?
- With a volume of 10,194,854, the price of AUPH is down -1.96% at $11.78.
- RSI indicators hint that the underlying stock may be oversold.
- Next earnings are expected to be released in 64 days.
What The Experts Say On Aurinia Pharmaceuticals:
- RBC Capital has decided to maintain their Outperform rating on Aurinia Pharmaceuticals, which currently sits at a price target of $27.
- RBC Capital has decided to maintain their Outperform rating on Aurinia Pharmaceuticals, which currently sits at a price target of $31.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you are already an options trader or would like to get started, head on over to Benzinga Pro. Benzinga Pro gives you up-to-date news and analytics to empower your investing and trading strategy.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
